BioNTech SE (BioNTech SE) Other Current Payables : $0 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is BioNTech SE Other Current Payables?

BioNTech SE's Other Current Payables for the quarter that ended in Dec. 2023 was $0 Mil.

BioNTech SE's quarterly Other Current Payables increased from Jun. 2023 ($-0 Mil) to Sep. 2023 ($0 Mil) and increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($0 Mil).

BioNTech SE's annual Other Current Payables stayed the same from Dec. 2021 ($0 Mil) to Dec. 2022 ($0 Mil) but then increased from Dec. 2022 ($0 Mil) to Dec. 2023 ($0 Mil).

BioNTech SE Other Current Payables Historical Data

The historical data trend for BioNTech SE's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Other Current Payables Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

BioNTech SE Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Payables	Get a 7-Day Free Trial															-	-	-	-	-

BioNTech SE Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

BioNTech SE Other Current Payables Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE (BioNTech SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (NAS:BNTX) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.